New therapies to treat naturally occurring eye diseases focus of $6 million grant from the National Eye Institute
October 17, 2018
Grant supports leading-edge research to better understand and develop novel regenerative therapies for vision loss and blindness
UC Davis Health's clinical trials directory recognized among most innovative at global clinical research summit
October 16, 2018
The Clinical Studies website is a resource for those who may be interested in participating in research studies at UC Davis Health. Easy-to-understand language, sharing options and online sign ups among the popular features.
October 15, 2018
Those who are beginning their careers in academic medicine as well as faculty who mentor students are invited to attend the Intentional Mentoring event as well as sessions on the merits and promotions process and speed-mentoring rotations with senior faculty and leadership, Oct. 24. Lunch for those who pre-register by Oct. 20
October 2, 2018
Megan Dennis of the UC Davis MIND Institute and Genome Center is the recipient of the NIH Director’s New Innovator Award to study genes unique to humans that may contribute to neurodevelopmental disorders including autism.
October 1, 2018
Better, more precise care for military personnel and civilians who suffer traumatic brain injury along with burns or other forms of trauma is in the work thanks to a new grant from Department of Defense that's been awarded toresearchers and clinical care specialists at UC Davis Health.
September 19, 2018
New studies from UC Davis Health are among the first to associate fractures with systemic bone loss. They also begin the path to finding treatments that preserve long-term skeletal health and reduce susceptibility to additional fractures and, potentially, osteoporosis.
September 7, 2018
Junior faculty who are interested in pursuing careers as independent clinical researchers are invited to apply for the KL2 Mentored Career Development program.
September 6, 2018
Investigators at the UC Davis MIND Institute and NeuroPointDX, a division of Stemina Biomarker Discovery, have identified a group of blood metabolites that could help detect some children with autism spectrum disorder (ASD). Part of the Children’s Autism Metabolome Project (CAMP), the largest metabolomic ASD study ever attempted, these findings are a key step toward developing an ASD biomarker test. The research was published September 6 in the journal Biological Psychiatry.
University of California Firearms Violence Research Center announces call for research proposals on the prevention of firearm violence in California
September 5, 2018
UCFC, the firearm research center funded with an appropriation from the state in 2016 and housed within the Violence Prevention Research Program at UC Davis, aims to catalyze research, awarding grants of up to $10,000.
August 21, 2018
A comprehensive analysis of eight clinical trials and four cohort studies on cervical cancer screening by researchers from UC Davis and Kaiser Permanente Northwest has found that while Pap smears are still highly effective for detecting pre-cancerous cells and cancer, testing for the virus that causes these cancers also is an excellent screening tool.
August 13, 2018
Nine teams, including UC Davis stem cell researchers, pursue a cure for rare disorder with links to autism, Alzheimer's disease and cancer
August 13, 2018
Better treatments and improved screening programs that detect cancer at earlier stages led to an overall 12 percent improvement in cancer survival in California, according to a new report from the UC Davis Institute for Population Health Improvement.
August 7, 2018
Oanh Meyer’s mother Anh Le, arrived in the United States in 1975 as a Vietnam War refugee just a few days before the fall of Saigon. And while she settled in America and raised a family, the trauma of living in war-torn Vietnam throughout the conflict took a toll on her.
August 6, 2018
Researchers at UC Davis, Genentech and Foundation Medicine are the first to show that a blood-based test to assess tumor mutational burden (TMB) accurately identifies non-small cell lung cancer (NSCLC) patients who could benefit from immunotherapies called checkpoint inhibitors. The blood test offers a much less invasive and more repeatable alternative to tissue testing. The study was published online today in Nature Medicine.